RxDoctor Payments Data

Arturo Garcia, MD

General Practice · Patillas, PRNPI 1356357552

Payments from drug & device makers

$1,262in general payments, 2019–2025

Across 44 payments — averaging $28.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$295
  • Merck$241
  • Janssen Products, LP$190
  • AbbVie$138
  • PBG Puerto Rico LLC$109
  • Alafair Biosciences, Inc.$99
  • plus $190 from 5 others

What the payments were for

  • Food & beverage$1,04783%
  • Education$21617%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,262 in reported general payments places this provider in the 85th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$2,975
Medicare patients
19
Services billed
90

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib11$72,421
PrezcobixDarunavir/Cobicistat26$63,347
DovatoDolutegravir Sodium/Lamivudine11$32,342
DescovyEmtricitabine/Tenofov Alafenam13$28,342
IsentressRaltegravir Potassium13$25,697
XareltoRivaroxaban29$21,077
EliquisApixaban18$18,876
TrulicityDulaglutide17$16,789
Maraviroc13$14,382
SynjardyEmpagliflozin/Metformin Hcl19$12,116
ShingrixVaricella-Zoster Ge/As01b/Pf24$5,141
LantusInsulin Glargine,hum.Rec.Anlog38$4,636
SynthroidLevothyroxine Sodium63$4,290
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip69$2,208
Atorvastatin Calcium183$1,592

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonPrezcobix, Xarelto$295$84,42455 claims
AbbVieRinvoq, Synthroid$138$76,71074 claims
MerckIsentress$241$25,69713 claims
Boehringer IngelheimSynjardy$92$12,11619 claims
GSKShingrix$41$5,14124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in Patillas

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →